FCED
MCID: FCH001
MIFTS: 44

Fuchs' Endothelial Dystrophy (FCED)

Categories: Eye diseases, Gastrointestinal diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Fuchs' Endothelial Dystrophy

MalaCards integrated aliases for Fuchs' Endothelial Dystrophy:

Name: Fuchs' Endothelial Dystrophy 12 25 43 15
Fuchs Endothelial Corneal Dystrophy 52 25 58 29
Late Hereditary Endothelial Dystrophy 52 58
Endoepithelial Corneal Dystrophy 52 58
Fuchs Endothelial Dystrophy 25 71
Fuchs Corneal Dystrophy 25 36
Fecd 52 58
Corneal Dystrophy, Fuchs' Endothelial, 1 71
Dystrophy, Corneal, Fuchs Endothelial 39
Fuchs' Endothelial Corneal Dystrophy 12
Corneal Dystrophy, Fuchs Endothelial 54
Fuchs' Corneal Dystrophy 12
Fuchs Dystrophy 25
Fuchs Atrophy 25
Fced 12

Characteristics:

Orphanet epidemiological data:

58
fuchs endothelial corneal dystrophy
Inheritance: Autosomal dominant,Multigenic/multifactorial,Not applicable; Age of onset: Adult;

Classifications:

Orphanet: 58  
Rare eye diseases


External Ids:

Disease Ontology 12 DOID:11555
KEGG 36 H00960
MeSH 43 D005642
NCIt 49 C84721
SNOMED-CT 67 193839007
ICD10 32 H18.51
ICD10 via Orphanet 33 H18.5
UMLS via Orphanet 72 C0016781
Orphanet 58 ORPHA98974
UMLS 71 C0016781 C1850959

Summaries for Fuchs' Endothelial Dystrophy

NIH Rare Diseases : 52 Fuchs endothelial corneal dystrophy (FECD) is an eye disease . It affects the thin layer of cells that line the back part of the cornea. This layer is called the endothelium. The disease occurs when these cells slowly start to die off. The cells help pump excess fluid out of the cornea. As more and more cells are lost, fluid begins to build up in the cornea, causing swelling and a cloudy cornea . There are several forms of the disease according to the age of onset of the symptoms and the cause. The early-onset form is very rare and is known as Fuchs endothelial corneal dystrophy 1 (or early-onset Fuchs endothelial corneal dystrophy) and it is caused by a change (mutation ) in the COL8A2 gene . Late-onset Fuchs endothelial corneal dystrophies are common and include: Fuchs endothelial corneal dystrophy 2 (caused by a mutation in an unknown gene located in chromosome 13 ) Fuchs endothelial corneal dystrophy 3 (may be caused by TCF4 gene mutations) Fuchs endothelial corneal dystrophy 4 (caused by a mutation in the SLC4A11 gene ) Fuchs endothelial corneal dystrophy 5 (caused by a mutation in an unknown gene located in chromosome 15 ) Fuchs endothelial corneal dystrophy 6 (caused by a mutation in the ZEB1 gene ) Fuchs endothelial corneal dystrophy 7 (caused by a mutation in an unknown gene located in chromosome 9 ) Fuchs endothelial corneal dystrophy 8 (caused by heterozygous mutation in the AGBL1 gene ). Early in the disease, patients typically do not have symptoms. In the late-onset forms, the symptoms start around 50 or 60 years and include discomfort and painful episodes of recurrent corneal wounds and hazy vision. Over time, discomfort may diminish but severe impairment of visual acuity, and even blindness and cataracts in elderly patients, may be observed. Once the vision has worsened, the recommended treatment is a penetrating graft which has excellent results in most cases.

MalaCards based summary : Fuchs' Endothelial Dystrophy, also known as fuchs endothelial corneal dystrophy, is related to corneal edema and corneal dystrophy. An important gene associated with Fuchs' Endothelial Dystrophy is COL8A2 (Collagen Type VIII Alpha 2 Chain), and among its related pathways/superpathways are Detoxification of Reactive Oxygen Species and Prostaglandin 2 biosynthesis and metabolism FM. The drugs Prednisolone phosphate and Methylprednisolone have been mentioned in the context of this disorder. Affiliated tissues include endothelial, eye and testes.

Disease Ontology : 12 A corneal dystrophy characterized by accumulation of focal outgrowths (guttae) and thickening of Descemet's membrane, leading to corneal edema and loss of vision.

Genetics Home Reference : 25 Fuchs endothelial dystrophy is a condition that causes vision problems. The first symptom of this condition is typically blurred vision in the morning that usually clears during the day. Over time, affected individuals lose the ability to see details (visual acuity). People with Fuchs endothelial dystrophy also become sensitive to bright lights. Fuchs endothelial dystrophy specifically affects the front surface of the eye called the cornea. Deposits called guttae, which are detectable during an eye exam, form in the middle of the cornea and eventually spread throughout the cornea. These guttae contribute to the ongoing cell death within the cornea, leading to worsening vision problems. Tiny blisters may develop on the cornea, which can burst and cause eye pain. The signs and symptoms of Fuchs endothelial dystrophy usually begin in a person's forties or fifties. A very rare early-onset variant of this condition starts to affect vision in a person's twenties.

KEGG : 36 Fuchs endothelial corneal dystrophy (FECD) is characterized by progressive loss of corneal endothelial cells, thickening of Descemet membrane, and deposition of extracellular matrix in the form of guttae. As a result, the endothelial layer is eventually no longer able to support corneal deturgescence, leading to corneal edema and decreased in visual acuity. These findings usually become clinically evident in the fourth and fifth decades of life. Corneal transplantation is currently the only modality used to restore vision. FECD is a genetically complex disorder, but the familial risk is relatively high.

Related Diseases for Fuchs' Endothelial Dystrophy

Diseases related to Fuchs' Endothelial Dystrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 84)
# Related Disease Score Top Affiliating Genes
1 corneal edema 31.9 ZEB1 VSX1 SLC4A11 LOXHD1 COL8A2
2 corneal dystrophy 31.5 ZEB1 VSX1 TGFBI TCF4 SLC4A11 LOXHD1
3 keratoconus 31.5 VSX1 TGFBI SLC4A11 COL8A2 COL8A1
4 irregular astigmatism 31.4 VSX1 TGFBI SLC4A11 COL8A2
5 corneal dystrophy and perceptive deafness 31.2 VSX1 SLC4A11 LOXHD1 COL8A2
6 secondary corneal edema 31.1 SLC4A11 LOXHD1 COL8A2
7 corneal dystrophy, posterior polymorphous, 3 31.1 ZEB1 VSX1 SLC4A11 COL8A2
8 corneal dystrophy, posterior polymorphous, 2 31.1 ZEB1 VSX1 SLC4A11 COL8A2
9 corneal disease 31.0 ZEB1 VSX1 TGFBI SLC4A11 PITX2 LOXHD1
10 corneal ectasia 31.0 VSX1 COL8A2
11 corneal dystrophy, posterior polymorphous, 1 31.0 ZEB1 VSX1 TGFBI SLC4A11 LOXHD1 COL8A2
12 interstitial keratitis 30.8 TGFBI COL8A2
13 corneal endothelial dystrophy 30.8 ZEB1 VSX1 TGFBI SLC4A11 LOXHD1 KANK4
14 corneal dystrophy, fuchs endothelial, 1 11.9
15 corneal dystrophy, fuchs endothelial, 5 11.8
16 astigmatism 10.6
17 corneal dystrophy, endothelial, x-linked 10.6 VSX1 SLC4A11 COL8A2
18 cataract 10.6
19 recurrent corneal erosion 10.6 TGFBI LINC00970 COL8A2
20 macular dystrophy, corneal 10.6 TGFBI SLC4A11 COL8A2
21 corneal degeneration 10.6 VSX1 TGFBI SLC4A11 COL8A2
22 epithelial and subepithelial dystrophy 10.6 TGFBI SLC4A11 COL8A2
23 posterior corneal dystrophy 10.6 ZEB1 COL8A2
24 granular corneal dystrophy 10.6 TGFBI SLC4A11 COL8A2
25 bullous keratopathy 10.6
26 keratopathy 10.6
27 stromal dystrophy 10.6 TGFBI SLC4A11 COL8A2
28 corneal dystrophy, fleck 10.5 SLC4A11 LOXHD1 COL8A2
29 epithelial basement membrane dystrophy 10.5 TGFBI COL8A2
30 brittle cornea syndrome 2 10.5 VSX1 SLC4A11 COL8A2
31 anterior segment dysgenesis 10.5 VSX1 TGFBI PITX2
32 myotonic dystrophy 10.5
33 corneal dystrophy, band-shaped 10.5 SLC4A11 COL8A2
34 corneal dystrophy, thiel-behnke type 10.5 TGFBI COL8A2
35 corneal dystrophy, fuchs endothelial, 3 10.4
36 corneal dystrophy, gelatinous drop-like 10.4 TGFBI COL8A2
37 corneal dystrophy, avellino type 10.3 TGFBI COL8A2
38 microvascular complications of diabetes 5 10.3
39 corneal dystrophy, fuchs endothelial, 6 10.3
40 corneal dystrophy, fuchs endothelial, 2 10.2
41 joint laxity, short stature, and myopia 10.2
42 regular astigmatism 10.2
43 myopia 10.2
44 senile cataract 10.2
45 refractive error 10.2
46 corneal dystrophy, meesmann, 1 10.2 TGFBI COL8A2
47 amyotrophic lateral sclerosis 1 10.2
48 retinitis pigmentosa 10.2
49 kearns-sayre syndrome 10.2
50 alveolar soft part sarcoma 10.2

Graphical network of the top 20 diseases related to Fuchs' Endothelial Dystrophy:



Diseases related to Fuchs' Endothelial Dystrophy

Symptoms & Phenotypes for Fuchs' Endothelial Dystrophy

Drugs & Therapeutics for Fuchs' Endothelial Dystrophy

Drugs for Fuchs' Endothelial Dystrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 41)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
2
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
3
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
4
Loteprednol Approved, Experimental Phase 4 129260-79-3, 82034-46-6 9865442 444025
5 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
6
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
7
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
8 Protective Agents Phase 4
9 Gastrointestinal Agents Phase 4
10 Hormones Phase 4
11 Methylprednisolone Acetate Phase 4
12 Antineoplastic Agents, Hormonal Phase 4
13 Anti-Allergic Agents Phase 4
14 Hormone Antagonists Phase 4
15 glucocorticoids Phase 4
16 Antiemetics Phase 4
17 Neuroprotective Agents Phase 4
18 Anti-Inflammatory Agents Phase 4
19 Ophthalmic Solutions Phase 4
20
Fluorometholone Approved, Investigational Phase 2 426-13-1 9878
21
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2 1177-87-3
22
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
23
Acetylcysteine Approved, Investigational Phase 2 616-91-1 12035
24
Cysteine Approved, Nutraceutical Phase 2 52-90-4 5862
25 BB 1101 Phase 2
26 Lubricant Eye Drops Phase 2
27 Respiratory System Agents Phase 2
28 Antidotes Phase 2
29 Expectorants Phase 2
30 Antioxidants Phase 2
31 Antiviral Agents Phase 2
32 N-monoacetylcystine Phase 2
33
Letrozole Approved, Investigational 112809-51-5 3902
34
Fluorouracil Approved 51-21-8 3385
35
Anastrozole Approved, Investigational 120511-73-1 2187
36
Docetaxel Approved, Investigational 114977-28-5 148124
37
Cyclophosphamide Approved, Investigational 50-18-0, 6055-19-2 2907
38
Tamoxifen Approved 10540-29-1 2733526
39
Hyaluronic acid Approved, Vet_approved 9004-61-9 53477741
40
Ketotifen Approved 34580-13-7, 34580-14-8 3827
41
Dipivefrin Approved 52365-63-6 3105

Interventional clinical trials:

(show top 50) (show all 64)
# Name Status NCT ID Phase Drugs
1 Prospective, Randomized Comparison of Corticosteroid Dosing Regimens Following Endothelial Keratoplasty Completed NCT01853696 Phase 4 loteprednol etabonate;prednisolone acetate 1%
2 Fuchs' Endothelial Dystrophy and Cataract Surgery: Can Torsional Phacoemulsification Decrease the Risk for Corneal Decompensation Completed NCT00781027 Phase 4
3 Intrastromal Corneal Ring Segment Implantation for High Astigmatism on Postkeratoplasty Eyes Completed NCT01018797 Phase 4
4 A Pilot Study For Efficacy And Safety Of Glanatec® Opthalmic Solution 0.4% On Corneal Edema And Endothelial Cell Counts In Subjects With Fuchs Endothelial Dystrophy Undergoing Descemet Stripping Without Endothelial Keratoplasty Recruiting NCT03249337 Phase 4 Ripasudil hydrochloride hydrate 0.4% ophthalmic solution
5 Randomized, Double-masked, Placebo-controlled Evaluation of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation Completed NCT03248037 Phase 3 Netarsudil;Placebo
6 Prospective Randomized Study to Determine Whether Use of Rhopressa™ Can Ameliorate Corneal Edema Associated With Fuchs Dystrophy Recruiting NCT04051463 Phase 2, Phase 3 Netarsudil Ophthalmic Solution;Placebo
7 Prospective Randomized Study to Determine Whether Use of Rhopressa™ Accelerates Corneal Clearing After Removal of Descemet Membrane for Treatment of Fuchs Dystrophy Recruiting NCT03971357 Phase 2, Phase 3 Netarsudil;Placebo
8 A Randomized, Double-masked, Placebo-controlled Study of the Safety of Amphotericin 0.255 μg/mL in Optisol-GS Withdrawn NCT04018417 Phase 2, Phase 3 Amphotericin B
9 Comparison Of Two Corticosteroid Dosing Regimens For Prevention Of Corneal Transplant Rejection Episodes After Descemet's Membrane Endothelial Keratoplasty Completed NCT01448213 Phase 2 Prednisolone acetate;Fluorometholone
10 Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone: Tolerance and Safety Pilot Study Completed NCT02834260 Phase 2 Dexamethasone implant OZURDEX
11 PART A: A PROSPECTIVE, RANDOMIZED, DOUBLE-MASKED, VEHICLE CONTROLLED, PAIRED-EYE PHASE 1/2 CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF ELAMIPRETIDE TOPICAL OPHTHALMIC SOLUTION IN SUBJECTS WITH FCED PRESENTING WITH MILD TO MODERATE CORNEAL EDEMA PART B: A PROSPECTIVE, RANDOMIZED, DOUBLE-MASKED, VEHICLE CONTROLLED, PHASE 1/2 CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF ELAMIPRETIDE TOPICAL OPHTHALMIC SOLUTION IN SUBJECTS WITH FCED PRESENTING WITH MILD TO MODERATE CORNEAL EDEMA Completed NCT02653391 Phase 1, Phase 2 Elamipretide 1.0% Ophthalmic Solution;Elamipretide 3.0% Ophthalmic Solution
12 A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12 Week, Phase 2 Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Patients With Fuchs Endothelial Corneal Dystrophy Recruiting NCT04250207 Phase 2 K-321 Solution;Placebo Solution
13 A Phase II, Interventional, Double-blind, Single-center Study of the Effects of Ripasudil on Cornea Clearing After Descemet Membrane Endothelial Keratoplasty in Subjects With Fuchs' Endothelial Corneal Dystrophy Recruiting NCT03813056 Phase 2 Glanatec;Optive, Ophthalmic Solution
14 Prospective Single-centre Randomized Observer-blind Placebo-controlled Parallel-group Phase IIa Clinical Trial to Investigate the Safety and Efficacy of Ripasudil 0.4% Eye Drops After Descemetorhexis in Patients With Moderate to Advanced Fuchs Endothelial Corneal Dystrophy (FECD) Recruiting NCT03575130 Phase 2 Ripasudil eye drops;Optive eye drops
15 Assessment of Corneal Endothelial Function Following Hypoxic Stress Recruiting NCT04175938 Phase 1, Phase 2
16 Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy Not yet recruiting NCT04440280 Phase 2 N-acetyl cysteine (NAC) 10% solution;N-acetyl cysteine (NAC) 20% solution;Visine Dry Eye Relief eye drops
17 Phase 1 Clinical Study to Evaluate Safety and Tolerability of Magnetic Human Corneal Endothelial Cells in the Treatment of Corneal Edema Recruiting NCT04191629 Phase 1
18 Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty (TE-EK) Recruiting NCT04319848 Phase 1
19 Prospective Clinical Study on Postoperative Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) Unknown status NCT02020044
20 Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) in Patients With Corneal Endothelial Cell Dysfunction: Clinical Outcomes and Diagnostic Imaging Analysis Unknown status NCT00744796
21 In Vitro and Clinical Comparison of Corneal Grafts Cultured in Serum Free Medium or Standard Serum Supplemented Medium in Patients With Degeneration of the Corneal Endothelium Unknown status NCT00623584
22 DSAEK- Postoperative Positioning and Transplant Dislocation Unknown status NCT01206127
23 Prospective Randomized Study Comparing Endothelial Cell Loss Using the Tan EndoGlide With the Endoserter for Insertion of the Donor Graft in Descemets Stripping Endothelial Keratoplasty (DSAEK) Unknown status NCT01791075
24 The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy Completed NCT01795001
25 Combined Cataract Surgery and Planned Descemetorhexis Completed NCT02206594
26 Fuchs' Endothelial Dystrophy: Clinical Characteristics, Treatment Outcome, and Pathology Completed NCT01979250
27 Corneal Transplantation by DMEK - is it Really Better Than DSAEK? Completed NCT02793310
28 Open-enrollment, Prospective Study of Endothelial Keratoplasty Outcomes Completed NCT00800111
29 Comparative Long-term Results After DSAEK, UT-DSAEK and DMEK for Fuchs Endothelial Corneal Dystophy and Moderated Pseudophakic Bullous Keratopathy Completed NCT04424550
30 Escala de Riesgo de descompensación Corneal en cirugía de Catarata en Pacientes Con Distrofia Corneal de Fuchs Completed NCT04072029
31 ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy Completed NCT02332109
32 A Prospective, Randomized, Single Center Study Evaluating Use of Surgeon- and Eye Bank-prepared Donor Tissue for Descemet's Stripping and Endothelial Keratoplasty, a Type of Cornea Transplant Completed NCT00624221
33 Long Term Cornea Graft Survival Study (Étude Bisontine d'Estimation de la Survie à Long Terme à Partir Des données de Suivi Internes au CHRU : Evaluation Epidémiologie Clinique) Completed NCT02849808
34 Impact of Cataract Surgery on Keratoplasty Graft Survival Completed NCT02875145
35 Cornea Donor Study: The Effect of Donor Age on Penetrating Keratoplasty for Endothelial Disease Completed NCT00006411
36 Prospective Intraoperative and Perioperative Ophthalmic Imaging With Optical Coherence Tomography: PIONEER Study Completed NCT02423161
37 The Effect of Hydrodynamic Parameters on Corneal Endothelial Cell Loss After Phacoemulsification Completed NCT00370955
38 Comparison of Manual and Automated Techniques in Achieving Posterior Lamellar Transplantation of the Cornea Completed NCT01610973
39 Deep Lamellar Endothelial Keratoplasty as Surgical Treatment for Corneal Endothelial Decompensation Completed NCT00346138
40 Study of the Efficiency and Workflow of Femtosecond Laser Assisted Cataract Surgery in a Spanish Public Hospital Completed NCT03931629
41 Relationship Between Preoperative Corneal Thickness and Postoperative Completed NCT03355911
42 Impact of Graft Thickness on Visual Gain After Descemet's Stripping Automated Endothelial Keratoplasty Completed NCT02883855
43 Factors Affecting Corneal Hysteresis in Taiwanese Completed NCT01235780
44 To Investigate the Precision and Agreement of SS-1000 and the Predicate Device Pentacam in a Repeatability and Reproducibility Trial (PASP) Completed NCT02077790
45 Predictive Modelling of Short Term Outcomes Following Systemic Neo-adjuvant and Adjuvant Therapy in Breast Cancer Patients Completed NCT01563211
46 Efficacy of Hyperosmolar Eye Drops in Diurnal Corneal Edema in Fuchs Endothelial Dystrophy: a Double Blind Randomized Controlled Trial Recruiting NCT04140422
47 Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France. The French Fuchs' Follow-up Study, F3S Recruiting NCT03974230
48 Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following Descemet's Membrane Endothelial Keratoplasty Using Ultra-high Resolution Optical Coherence Tomography Recruiting NCT02542644
49 The Postoperative Head Position as a Predictor of the Surgical Outcome After DMEK Recruiting NCT04387331
50 Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK) Recruiting NCT03407755

Search NIH Clinical Center for Fuchs' Endothelial Dystrophy

Cochrane evidence based reviews: fuchs' endothelial dystrophy

Genetic Tests for Fuchs' Endothelial Dystrophy

Genetic tests related to Fuchs' Endothelial Dystrophy:

# Genetic test Affiliating Genes
1 Fuchs Endothelial Corneal Dystrophy 29

Anatomical Context for Fuchs' Endothelial Dystrophy

MalaCards organs/tissues related to Fuchs' Endothelial Dystrophy:

40
Endothelial, Eye, Testes, Breast

Publications for Fuchs' Endothelial Dystrophy

Articles related to Fuchs' Endothelial Dystrophy:

(show top 50) (show all 831)
# Title Authors PMID Year
1
British family with early-onset Fuchs' endothelial corneal dystrophy associated with p.L450W mutation in the COL8A2 gene. 61 6 54
18024822 2007
2
Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity. 6 61
29526280 2018
3
RNA toxicity and missplicing in the common eye disease fuchs endothelial corneal dystrophy. 61 6
25593321 2015
4
TCF4 Triplet Repeat Expansion and Nuclear RNA Foci in Fuchs' Endothelial Corneal Dystrophy. 61 6
25722209 2015
5
Association of ZEB1 and TCF4 rs613872 changes with late onset Fuchs endothelial corneal dystrophy in patients from northern India. 6 61
26622166 2015
6
Comprehensive assessment of genetic variants within TCF4 in Fuchs' endothelial corneal dystrophy. 6 61
25168903 2014
7
Association and familial segregation of CTG18.1 trinucleotide repeat expansion of TCF4 gene in Fuchs' endothelial corneal dystrophy. 61 6
24255041 2014
8
L450W and Q455K Col8a2 knock-in mouse models of Fuchs endothelial corneal dystrophy show distinct phenotypes and evidence for altered autophagy. 61 6
23422828 2013
9
An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. 61 6
22002996 2012
10
Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. 61 6
11689488 2001
11
Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4. 6
24094747 2013
12
Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p. 6
20036349 2010
13
Q455V mutation in COL8A2 is associated with Fuchs' corneal dystrophy in Korean patients. 6
18464802 2009
14
Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). 6
16767101 2006
15
Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of fuchs corneal dystrophy. 6
15914606 2005
16
Inheritance of Fuchs' combined dystrophy. 6
399801 1979
17
Genetic analysis of patients with Fuchs endothelial corneal dystrophy in India. 54 61
20144242 2010
18
Genome-wide linkage scan in fuchs endothelial corneal dystrophy. 61 54
18502986 2009
19
No pathogenic mutations identified in the COL8A1 and COL8A2 genes in familial Fuchs corneal dystrophy. 61 54
16936088 2006
20
Analysis of COL8A2 gene mutation in Japanese patients with Fuchs' endothelial dystrophy and posterior polymorphous dystrophy. 61 54
15175909 2004
21
Repeatability of Scheimpflug Tomography for Assessing Fuchs Endothelial Corneal Dystrophy. 61
32112772 2020
22
Diagnostic Performance of 3-Dimensional Thickness of the Endothelium-Descemet Complex in Fuchs' Endothelial Cell Corneal Dystrophy. 61
32107067 2020
23
Descemet Membrane Endothelial Keratoplasty: Development of Contrast Sensitivity and Color Vision in Patients With Fuchs Endothelial Corneal Dystrophy. 61
32243420 2020
24
Effect of Iris Color on the Outcome of Descemet Membrane Endothelial Keratoplasty. 61
32195753 2020
25
A family of fuchs endothelial corneal dystrophy and anterior polar cataract with an analysis of whole exome sequencing. 61
32367751 2020
26
Overall clinical outcomes of Descemet membrane endothelial keratoplasty in 600 consecutive eyes: A large retrospective case series. 61
32461427 2020
27
Real-time intraoperative ultrasound biomicroscopy for determining graft orientation during Descemet's membrane endothelial keratoplasty. 61
32578923 2020
28
Bowman's layer in the cornea- structure and function and regeneration. 61
32339517 2020
29
Resolution of Corneal Fibrosis After Descemet's Stripping Automated Endothelial Keratoplasty: A Case Report. 61
32144575 2020
30
Implantation of Presbyopia-Correcting Intraocular Lenses Staged After Descemet Membrane Endothelial Keratoplasty in Patients With Fuchs Dystrophy. 61
31842037 2020
31
Morphological and Optical Determinants of Visual Disability in Fuchs Endothelial Corneal Dystrophy. 61
31868848 2020
32
Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis. 61
32438095 2020
33
Descemet Membrane Endothelial Keratoplasty in Asian Eyes: Intraoperative and Postoperative Complications. 61
32452991 2020
34
Descemet Membrane Endothelial Keratoplasty With a Pull-Through Insertion Device: Surgical Technique, Endothelial Cell Loss, and Early Clinical Results. 61
31996538 2020
35
Endothelial cell loss after Descemet's membrane endothelial keratoplasty for Fuchs endothelial dystrophy: DMEK compared to triple-DMEK. 61
32437670 2020
36
Trinucleotide repeat expansion in the transcription factor 4 (TCF4) gene in Thai patients with Fuchs endothelial corneal dystrophy. 61
31554942 2020
37
Analyzing pre-symptomatic tissue to gain insights into the molecular and mechanistic origins of late-onset degenerative trinucleotide repeat disease. 61
32463444 2020
38
Morning Myopic Shift and Glare in Advanced Fuchs Endothelial Corneal Dystrophy. 61
31954712 2020
39
Correlation Between Angle Parameters and Central Corneal Thickness in Fuchs Endothelial Corneal Dystrophy. 61
31842041 2020
40
Endothelial Cell Density Changes in the Corneal Center Versus Paracentral Areas After Descemet Membrane Endothelial Keratoplasty. 61
32282357 2020
41
Chronology of cellular events related to mitochondrial burnout leading to cell death in Fuchs endothelial corneal dystrophy. 61
32242036 2020
42
Clinical Outcomes and Endothelial Cell Density After Descemet Membrane Endothelial Keratoplasty Using Peripherally-trephinated Donor Tissue (DMEK-pD) in Fuchs Endothelial Corneal Dystrophy. 61
31517722 2020
43
Femtosecond laser-assisted Descemet's stripping endothelial keratoplasty: a prospective study of 6-month visual outcomes, corneal thickness and endothelial cell loss. 61
32318937 2020
44
Effect of Surgical Indication and Preoperative Lens Status on Descemet Membrane Endothelial Keratoplasty Outcomes. 61
31863726 2020
45
Five-Year Graft Survival and Clinical Outcomes of 500 Consecutive Cases After Descemet Membrane Endothelial Keratoplasty. 61
31478948 2020
46
Descemet Stripping Only for a Chronic Descemet Detachment After Cataract Surgery. 61
31725698 2020
47
Epithelial downgrowth after Descemet membrane endothelial keratoplasty. 61
32162534 2020
48
Long-term outcome of descemet membrane endothelial keratoplasty (DMEK) following failed penetrating keratoplasty (PK). 61
32198835 2020
49
Descemet Membrane Endothelial Keratoplasty versus Ultrathin Descemet Stripping Automated Endothelial Keratoplasty: A Multicenter Randomized Controlled Clinical Trial. 61
32386811 2020
50
Refractive lens exchange with a trifocal intraocular lens in Fuchs endothelial dystrophy. 61
32050211 2020

Variations for Fuchs' Endothelial Dystrophy

Expression for Fuchs' Endothelial Dystrophy

Search GEO for disease gene expression data for Fuchs' Endothelial Dystrophy.

Pathways for Fuchs' Endothelial Dystrophy

Pathways related to Fuchs' Endothelial Dystrophy according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
10.66 PRDX6 PRDX5 PRDX3 PRDX2
2 10.49 PRDX5 PRDX3 PRDX2

GO Terms for Fuchs' Endothelial Dystrophy

Cellular components related to Fuchs' Endothelial Dystrophy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 collagen-containing extracellular matrix GO:0062023 9.26 TGFBI COL8A2 COL8A1 CLU
2 basement membrane GO:0005604 8.8 TGFBI COL8A2 COL8A1

Biological processes related to Fuchs' Endothelial Dystrophy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 oxidation-reduction process GO:0055114 9.83 PRDX6 PRDX5 PRDX3 PRDX2 LOXHD1
2 response to oxidative stress GO:0006979 9.62 PRDX6 PRDX5 PRDX3 PRDX2
3 cellular response to oxidative stress GO:0034599 9.56 PRDX6 PRDX5 PRDX3 PRDX2
4 cell redox homeostasis GO:0045454 9.46 PRDX6 PRDX5 PRDX3 PRDX2
5 camera-type eye morphogenesis GO:0048593 9.4 COL8A2 COL8A1
6 epithelial cell proliferation GO:0050673 9.37 COL8A2 COL8A1
7 hydrogen peroxide catabolic process GO:0042744 9.26 PRDX6 PRDX5 PRDX3 PRDX2
8 cellular oxidant detoxification GO:0098869 9.02 PRDX6 PRDX5 PRDX3 PRDX2 LOXHD1

Molecular functions related to Fuchs' Endothelial Dystrophy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peroxidase activity GO:0004601 9.56 PRDX6 PRDX5 PRDX3 PRDX2
2 extracellular matrix structural constituent GO:0005201 9.5 TGFBI COL8A2 COL8A1
3 cysteine-type endopeptidase inhibitor activity involved in apoptotic process GO:0043027 9.37 PRDX5 PRDX3
4 thioredoxin peroxidase activity GO:0008379 9.33 PRDX5 PRDX3 PRDX2
5 antioxidant activity GO:0016209 9.26 PRDX6 PRDX5 PRDX3 PRDX2
6 peroxiredoxin activity GO:0051920 8.92 PRDX6 PRDX5 PRDX3 PRDX2

Sources for Fuchs' Endothelial Dystrophy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....